Methods for making L-glufosinate

US11560577B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11560577-B2
Application numberUS-202016997133-A
CountryUS
Kind codeB2
Filing dateAug 19, 2020
Priority dateMar 2, 2016
Publication dateJan 24, 2023
Grant dateJan 24, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods for the production of L-glufosinate (also known as phosphinothricin or (S)-2-amino-4-(hydroxy(methyl)phosphonoyl)butanoic acid) are provided. The methods comprise a two-step process. The first step involves the oxidative deamination of D-glufosinate to PPO (2-oxo-4-(hydroxy(methyl)phosphinoyl)butyric acid). The second step involves the specific amination of PPO to L-glufosinate, using an amine group from one or more amine donors. By combining these two reactions, the proportion of L-glufosinate in a mixture of L-glufosinate and D-glufosinate can be substantially increased.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for making L-glufosinate, comprising: reacting D glufosinate with a D-amino acid oxidase (DAAO) enzyme to form PPO (2-oxo-4-(hydroxy(methyl)phosphinoyl)butyric acid) while aerating; and aminating the PPO to L-glufosinate by an L-amino acid dehydrogenase (LAAD) enzyme in the presence of an ammonia source, wherein at least 70% of the D-glufosinate is converted to L-glufosinate; and wherein the method is performed ex vivo. 2. The method according to claim 1 , wherein the D-glufosinate is originally present in a racemic mixture of D- and L-glufosinate or salts thereof. 3. The method according to claim 1 , wherein the DAAO enzyme has the amino acid sequence of SEQ ID NO: 2. 4. The method of claim 1 , wherein the DAAO enzyme is a mutant DAAO comprising one or more mutations at positions 54, 56, 58, 213, and 238, using SEQ ID NO: 2 as a reference sequence. 5. The method of claim 4 , wherein the mutation at position 54 is selected from the group consisting of N54C, N54L, N54T, and N54V. 6. The method of claim 4 , wherein the mutation at position 56 is T56M. 7. The method of claim 4 , wherein the mutation at position 58 is selected from the group consisting of F58A, F58G, F58H, F58K, F58N, F58Q, F58R, F58S, and F58T. 8. The method of claim 4 , wherein the mutation at position 213 is M213S. 9. The method of claim 4 , wherein the mutant DAAO comprises mutations at positions 54 and 56, using SEQ ID NO: 2 as a reference sequence. 10. The method of claim 4 , wherein the mutant DAAO comprises mutations F58Q or F58H, using SEQ ID NO: 2 as a reference sequence. 11. The method of claim 4 , wherein the mutant DAAO comprises mutations N54V and F58Q, using SEQ ID NO: 2 as a reference sequence. 12. The method of claim 4 , wherein the mutant DAAO comprises mutations N54V, F58Q, and M213S, using SEQ ID NO: 2 as a reference sequence. 13. The method of claim 1 , wherein the reacting step and the aminating step are performed in a single container. 14. The method of claim 13 , wherein all reagents are substantially added at the start of the reaction. 15. The method of claim 13 , wherein the reagents for the reacting step and the reagents for the aminating step are added to the single container at different times. 16. The method of claim 1 , wherein the reacting step and the aminating step are performed in separate containers. 17. The method of claim 1 , wherein the aerating comprises introducing oxygen, oxygen enriched air, an oxygen enriched gas stream, or air. 18. The method of claim 1 , wherein the aerating is conducted intermittently or continuously.

Assignees

Inventors

Classifications

  • C12P13/02Primary

    Amides, e.g. chloramphenicol {or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes (peptides C12P21/00 or C07K)} · CPC title

  • Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen {(phosphoglycerides, C12P7/6481)} · CPC title

  • C12P41/00Primary

    Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture · CPC title

  • containing acyclic or cycloaliphatic radicals · CPC title

  • characterised by the surfactants · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11560577B2 cover?
Methods for the production of L-glufosinate (also known as phosphinothricin or (S)-2-amino-4-(hydroxy(methyl)phosphonoyl)butanoic acid) are provided. The methods comprise a two-step process. The first step involves the oxidative deamination of D-glufosinate to PPO (2-oxo-4-(hydroxy(methyl)phosphinoyl)butyric acid). The second step involves the specific amination of PPO to L-glufosinate, using a…
Who is the assignee on this patent?
Basf Se
What technology area does this patent fall under?
Primary CPC classification C12P13/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).